Site-Specific Cutaneous Inflammation: Mechanisms and Therapeutic Implications.

Inflammatory skin diseases exhibit prominent anatomical distribution patterns that have long guided clinical diagnosis, yet the biological mechanisms underlying site specificity remain incompletely defined. These regional predilections arise from structural, immunological, and microbial heterogeneity across human skin. Epidermal barrier architecture, which varies substantially between body sites, including 10- to 100-fold differences in stratum corneum thickness, and prevalence and types of hair follicles and glands, creates distinct microenvironments that shape resident immune populations, microbial communities and host antimicrobial defenses. The skin harbors an estimated 20 billion tissue-resident memory T cells that persist within anatomically restricted niches, providing a mechanistic basis for disease recurrence at the same sites. In parallel, the skin microbiome contributes to regional specialization by forming distinct communities in oily, moist, and dry regions, which are disrupted in disease-specific ways, while environmental exposures such as ultraviolet radiation, mechanical stress, and humidity further reinforce regional variation. Recent advances in single-cell and spatial transcriptomic technologies have enabled inflammatory responses to be mapped with high precision, allowing detailed interrogation of site-specific cellular interactions and signaling pathways across the skin. Collectively, these findings support a unifying model in which regional tissue properties and local immune ecosystems shape disease-specific inflammatory circuits, accounting for the anatomical predilection of inflammatory diseases and underscoring the importance of tissue context for precision therapeutics.